ChitogenX (TSE:CHGX) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
ChitogenX Inc., a pioneering firm in regenerative medicine, has concluded its virtual Annual General Meeting, successfully re-electing six director nominees and appointing Audacie Inc. as its auditor. Shareholders displayed strong confidence, with over 90.82% votes in favor of the directorate, while the company continues to enhance tissue repair through its Chitosan Based Biopolymer technology platform.
For further insights into TSE:CHGX stock, check out TipRanks’ Stock Analysis page.